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Inhibitory interneurons regulate the oscillatory
rhythms and network synchrony that are required
for cognitive functions and disrupted in Alzheimer’s
disease (AD). Network dysrhythmias in AD and multi-
ple neuropsychiatric disorders are associated with
hypofunction of Nav1.1, a voltage-gated sodium
channel subunit predominantly expressed in inter-
neurons. We show that Nav1.1-overexpressing, but
not wild-type, interneuron transplants derived from
the embryonic medial ganglionic eminence (MGE)
enhance behavior-dependent gamma oscillatory ac-
tivity, reduce network hypersynchrony, and improve
cognitive functions in human amyloid precursor
protein (hAPP)-transgenic mice, which simulate key
aspects of AD. Increased Nav1.1 levels accelerated
action potential kinetics of transplanted fast-spiking
and non-fast-spiking interneurons. Nav1.1-deficient
interneuron transplants were sufficient to cause
behavioral abnormalities in wild-type mice. We
conclude that the efficacy of interneuron transplanta-
tion and the function of transplanted cells in an
AD-relevant context depend on their Nav1.1 levels.
Disease-specific molecular optimization of cell trans-
plantsmay be required to ensure therapeutic benefits
in different conditions.
INTRODUCTION
Alzheimer’s disease (AD) causes abnormal patterns of neuronal
network activity and cognitive decline through mechanisms thatremain to be fully elucidated (Palop and Mucke, 2010, 2016). In
preclinical and early stages of AD, functional imaging during
memory-encoding tasks shows hippocampal hyperactivation
and deactivation deficits in regions of the default mode network
(Bakker et al., 2012; Dickerson et al., 2005; Sperling et al., 2009).
The deactivation deficits correlate with early amyloid deposition
and accumulation in these regions (Buckner et al., 2005; Sperling
et al., 2009), suggesting an early pathological link between aber-
rant network activity and amyloid in AD. Aberrant network activ-
ity and pathologically elevated amyloid-b (Ab) levels are also
tightly linked in familial AD (FAD) mutant human amyloid precur-
sor protein (hAPP)-transgenic mice, which develop altered fast-
and slow-wave oscillatory activity (Busche et al., 2015; Cramer
et al., 2012; Rubio et al., 2012; Verret et al., 2012), neuronal
hyperactivity (Busche et al., 2008), activity-dependent amyloid
deposition (Bero et al., 2011; Yamamoto et al., 2015), and
network hypersynchrony, resulting in epileptiform activity that
is more often non-convulsive and behaviorally silent than convul-
sive and behaviorally evident (Palop et al., 2007). Humans with
AD—particularly those with FAD—also have an increased inci-
dence of seizures and epileptiform activity (for review, Palop
and Mucke, 2016), and recent studies suggest that the preva-
lence of these abnormalities among sporadic AD patients may
be vastly underestimated (Lam et al., 2017; Vossel et al., 2013;
Vossel et al., 2016). Impaired inhibitory function could be a key
mechanism of these functional abnormalities in mice and
humans (Bakker et al., 2012; Busche et al., 2008; Busche
et al., 2015; Palop and Mucke, 2016; Sperling et al., 2009; Verret
et al., 2012).
While network epileptiform activity can interfere with cognitive
functions (Kleen et al., 2013), physiological neuronal network
oscillations (brain rhythms) and network synchrony are required
for cognitive functions and are also regulated by inhibitory inter-
neurons (Kepecs and Fishell, 2014; Lapray et al., 2012; Sohal
et al., 2009). In humans andmice, increases in gamma oscillatoryNeuron 98, 1–15, April 4, 2018 ª 2018 Elsevier Inc. 1
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memory formation (Matsumoto et al., 2013; Sederberg et al.,
2007; Yamamoto et al., 2014). Gamma oscillatory activity can
be enhanced by optogenetic stimulation of parvalbumin (PV)-
positive inhibitory interneurons (PV cells) but not other cell types
(Cardin et al., 2009; Sohal et al., 2009), indicating a causal link
between PV cell function and gamma oscillations. In humans
with epilepsy and in hAPP mice, behaviorally induced gamma
oscillatory activity potently suppresses network hypersynchroni-
zation (Matsumoto et al., 2013; Verret et al., 2012). Many lines of
hAPP mice, including hAPP-J20, TgCRND8, Tg2576, and APP/
PS1 mice, have network hypersynchrony and altered gamma
oscillatory activity (Cramer et al., 2012; Gurevicius et al., 2013;
Hamm et al., 2017; Palop et al., 2007; Palop and Mucke, 2016;
Rubio et al., 2012; Verret et al., 2012).
In humans and mice, Nav1.1 is predominantly expressed in
interneurons, including PV and somatostatin (SOM) cells (Ogi-
wara et al., 2007; Rubinstein et al., 2015; Tai et al., 2014; Verret
et al., 2012; Wang et al., 2011). Selective Nav1.1 deletion in PV
and SOM cells impairs their excitability and action potential
(AP) generation (Rubinstein et al., 2015; Tai et al., 2014). Hypo-
function of Nav1.1 causes multiple epilepsy syndromes and
autism (D’Gama et al., 2015; Yu et al., 2006). Nav1.1 levels are
reduced in humans with AD and in multiple mouse models of
AD, including hAPP-J20, TgCRND8, and APP/PS1 mice
(Hamm et al., 2017; Hu et al., 2017; Verret et al., 2012). Nav1.1
levels can be restored by g-secretase inhibitors in TgCRND8
mice (Hamm et al., 2017). BACE1-dependent hypofunction of
Nav1.1 has also been reported in Tg2576- and BACE1-trans-
genic mice (Corbett et al., 2013; Kim et al., 2007), which may
involve enhanced cleavage of the b2-subunit of voltage-gated
sodium channels and impaired trafficking of the a subunits,
including Nav1.1, to the cell membrane. Importantly, restoring
Nav1.1 levels by expressing a bacterial artificial chromosome
(BAC) enhanced gamma oscillatory activity, reduced network
hypersynchrony, and improved cognitive performance in
hAPP-J20 mice (Verret et al., 2012), suggesting an important
functional role of Nav1.1-dependent interneuron hypofunction
in the pathogenesis of AD-related deficits.
Interneurons and neuronal network oscillations are altered in
multiple neurological andpsychiatric disorders, includingAD, ep-
ilepsy, schizophrenia, and autism (Fazzari et al., 2010; Kepecs
and Fishell, 2014; Sohal et al., 2009; Verret et al., 2012). Trans-
plantation of interneuron progenitors is a potential therapeutic
strategy for these conditions (Southwell et al., 2014). Interneuron
progenitor cells can be obtained from the embryonic medial
ganglionic eminence (MGE), the source of cortical PV and SOM
interneurons (Kepecs and Fishell, 2014; Southwell et al., 2014).
When transplanted into neonatal or adult brains, MGE-derived
progenitor cells (MGE cells) migrate, integrate into neuronal
circuits, and mature into functional inhibitory interneurons (Al-
varez-Dolado et al., 2006; Henderson et al., 2014; Howard
et al., 2014; Hunt et al., 2013). Hippocampal transplants of wild-
type MGE cells improve behavioral functions in mouse models
with extensive loss of hippocampal hilar interneurons, including
pilocarpine-treated mice (Casalia et al., 2017; Hunt et al., 2013)
and apolipoprotein E4 knockin (apoE4-KI) mice (Tong et al.,
2014), most likely by restoring interneuron cell numbers. How-2 Neuron 98, 1–15, April 4, 2018ever, it is unknown whether transplanted MGE cells can reduce
hAPP/Ab-dependent behavioral and network dysfunctions in
brains with chronically elevated levels of Ab in the absence of
extensive interneuron loss. Here we demonstrate that brain
transplants of wild-type, Nav1.1-overexpressing, or Nav1.1-defi-
cient interneuron progenitors have very different effects on
network and cognitive functions in hAPP-J20 and wild-type
mice, and we suggest that molecular modification to counteract
pathogenic contexts will likely be required to optimize the thera-
peutic efficacy of cell transplants for neurological disorders.
RESULTS
Transplanted MGE Cells Differentiate into Interneurons
and Survive in hAPP-J20 Mice
We chose hAPP-J20 (J20) mice as recipients for interneuron
transplants because they have robust cognitive deficits in the
Morris water maze and fear conditioning tests, network hyper-
synchrony, reduced gammaoscillatory power, andmultiple other
features that resemble AD in humans (Palop et al., 2007; Palop
et al., 2003; Palop and Mucke, 2016; Rubio et al., 2012; Verret
et al., 2012). To identify cortical and hippocampal inhibitory inter-
neurons derived from the MGE, we used BAC-transgenic mice
expressing green fluorescent protein (GFP) directed by Lhx6 reg-
ulatory sequences (Lhx6GFP mice). Lhx6GFP mice express GFP in
embryonic MGE progenitors (Cobos et al., 2006) and in mature
inhibitory interneurons, mainly PV and SOM cells (Figure 1A).
Consistent with the predominant expression of Nav1.1 in inhibi-
tory interneurons (Ogiwara et al., 2007; Rubinstein et al., 2015;
Tai et al., 2014; Verret et al., 2012; Yu et al., 2006), 97% of cells
with high Nav1.1 levels in Lhx6GFP mice were GFP positive (Fig-
ures 1B and 1C). Thus, Lhx6GFP-postive MGE-derived interneu-
rons express Nav1.1 and mature into PV and SOM interneurons.
To generate interneurons with increased Nav1.1 expression
(Verret et al., 2012), we bred Lhx6GFP and Scn1a-BAC mice to
produce doubly transgenic mice overexpressing wild-type
mouse Nav1.1 in GFP-positive interneurons (Lhx6GFPNav1.1-
BAC mice). On embryonic day 13.5, we isolated MGE cells with
wild-type Nav1.1 levels (MGEWT) from Lhx6GFP mice and MGE
cells overexpressing Nav1.1 (MGENav1.1) from Lhx6GFPNav1.1-
BACmice. Nontransgenic (NTG) and J20 littermatemice received
transplants of MGEWT or MGENav1.1 cells into cortex and hippo-
campus on postnatal (P) days 3–5. After 7 to 8months, GFP-pos-
itive cells in all groups (NTGMGE–WT, J20MGE–WT, NTGMGE–Nav1.1,
and J20MGE–Nav1.1) hadmature interneuronmorphology; predom-
inately expressed the interneuronmarkers SOM (39%), PV (31%),
or neuropeptide Y (7%); and displayed comparable and subtype-
appropriate localization across cortical layers (Figures 1D–1F).
Although transplanted GFP-positive interneurons were in all
cortical layers, GFP-positive PV cells were predominantly in inter-
mediate cortical layers (III–V), whereas GFP-positive SOM cells
were predominantly in superficial or deeper cortical layers (I, II,
or VI). Analysis of every tenth serial section throughout the cortex
and hippocampus showed that all groups of mice had compara-
ble spatial distribution and numbers of GFP-positive interneurons
(Figures 1G and S1B). We estimate that all groups had, on
average, 15,500–17,500 transplanted GFP-positive interneurons
per brain. Transplant-derived interneurons did not activate
Figure 1. Transplanted MGE-Derived Precursors Generate Nav1.1-Expressing Inhibitory Interneurons in Host NTG and J20 Brains
(A) Double-labeling for GFP (green) and PV (red, top) or SOM (red, bottom). GFP is expressed by PV (top) and SOM (bottom) inhibitory interneurons in Lhx6GFP
mice. Arrowheads indicate double-labeled cells.
(B) Double-labeling for Nav1.1 (red) and GFP (green). Nav1.1 is predominantly expressed by Lhx6GFP inhibitory interneurons. Arrowheads indicate double-
labeled cells.
(C) 97% of Nav1.1-positive cells were Lhx6GFP interneurons (n = 4 mice, 104 cells). (D) GFP-positive interneurons that were derived from Lhx6GFP MGENav1.1
precursor cells transplanted into 3–5-day-old J20 mice 7–8 months before analysis had mature morphology and extensive axonal and dendritic arborizations. At
7–8 months of age, J20 mice had Ab-positive plaques (red).
(E and F) MGE-derived interneurons predominantly expressed PV or SOM and were distributed in typical subtype-specific fashion across cortical layers. (E)
Double-labeling for GFP (green) and PV (red, top) or SOM (red, bottom). Transplanted GFP-positive PV cells were predominantly in intermediate cortical layers
(top, layer V), whereas GFP-positive SOM cells were predominantly in superficial cortical layers (bottom, layer I). (F) Proportions of MGEWT- and MGENav1.1-
derived interneurons in different cortical layers in NTG and J20 mice expressing PV, SOM, or neuropeptide Y (NPY) (n = 4 mice per group, 1449 GFP-posi-
tive cells).
(G) Number of MGEWT- and MGENav1.1-derived interneurons in NTG and J20 mice (n = 6–11 mice per group, 21696 GFP-positive cells).
Values are mean ± SEM. See also Figures S1 and S2.
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Figure 2. MGENav1.1 Cell Transplants Reduce Behavioral and Cognitive Deficits in J20 Mice
Mice received bilateral transplants at P3–5 (A–F) or at 2–3 months of age (G–I) and were tested at 4–7 months.
(A–F) P3–5 MGENav1.1, but not MGEWT, transplants reduced behavioral alterations in J20 mice, including hyperactivity in the open field (A) and Y-maze (B) and
enhanced freezing in the fear-conditioning test (C). MGENav1.1 cells improved performance in the hidden platform (spatial) component, escape distance (D), and
latency (E), and in the probe trial (F) of theMorris water maze test. n = 8–10mice per group. See Figure S3 for the learning curves of the same groups of mice in the
fear-conditioning test.
(G) Open-field activity before (trial 1) and after MGE cell transplantation (trials 2–4). J20MGE–Nav1.1 mice habituated faster than J20SHAM and J20MGE–WT mice.
n = 12–35 mice per J20 group.
(H) Open-field activity in trial 2.
(I) MGENav1.1, but not MGEWT, cells increased platform location preference in the water maze probe trial.
*p < 0.05, **p < 0.01, ***p < 0.001 versus NTG littermate controls by ANOVA and Bonferroni post hoc test (A, B, C, and H), or versus nontarget locations by paired
two-tailed t test (F and I). For J20SHAM versus J20MGE–Nav1.1 comparisons: #p < 0.05, ##p < 0.01, ###p < 0.001 by ANOVA and Bonferroni post hoc test (B, C, F, H,
and I) or by repeated-measures ANOVA and Bonferroni test (D and E, days 1–6) and (G, trials 2–4). See Figure S4 for J20WT versus J20MGE–Nav1 comparisons.
Values are mean ± SEM. Numbers in bars indicate numbers of mice. See also Figures S3 and S4.
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S1C and S1D). Thus, transplanted MGE cells differentiate into
interneurons and survive in J20 mice.
Low levels of cortical and hippocampal amyloid deposition
were present in 100% of 7- to 8-month-old J20 mice (Figure S2).
To determine whether transplant-derived interneurons modulate
early amyloid pathology in J20 mice 7 to 8 months after trans-
plantation, we measured hippocampal Ab-positive deposits by
immunostaining with the anti-Ab antibody 82E1. Compared to
sham-treated mice (J20SHAM), neither MGEWT- nor MGENav1.1-
derived cell transplants changed either the percent area occu-
pied by Ab deposits or the size or number of deposits in the4 Neuron 98, 1–15, April 4, 2018hippocampus of J20 mice (Figure S2). Hippocampal area per
se was also unaffected by MGE transplants (Figure S2).
Nav1.1-Overexpressing, but Not Wild-Type, Interneuron
Transplants Prevent and Reverse Behavioral Deficits in
J20 Mice
To determine whether Nav1.1 expression levels in MGE cells
modulate transplant efficacy in J20 mice, we transplanted
MGEWT or MGENav1.1 cells bilaterally into the cortex and hippo-
campus of J20 and NTG littermate mice at P3–P5 and analyzed
the mice at 4–7 months of age (Figures 2A–2F). Sham-trans-
planted littermate groups (NTGSHAM and J20SHAM) served as
Please cite this article in press as: Martinez-Losa et al., Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a
Mouse Model of Alzheimer’s Disease, Neuron (2018), https://doi.org/10.1016/j.neuron.2018.02.029controls. Compared to NTG littermate controls, J20SHAM and
J20MGE–WT mice displayed robust hyperactivity in the open field
(Figure 2A) and Y-maze (Figure 2B) and excessive freezing dur-
ing training in the fear-conditioning test (Figures 2C and S3),
whereas J20MGE–Nav1.1 mice did not (Figures 2A–2C and S3).
Compared to J20SHAM mice, J20MGE–Nav1.1 mice displayed less
hyperactivity and excessive freezing (Figures 2B and 2C).
Thus, MGEWT andMGENav1.1 cells likely differ in their therapeutic
efficacy in the presence of elevated levels of hAPP/Ab.
To determine whether early MGENav1.1 cell implantation also
reduces spatial learning and memory deficits in J20 mice,
we first tested NTGSHAM, J20SHAM, NTGMGE–Nav1.1, and
J20MGE–Nav1.1 mice in the Morris water maze. Compared to
NTGSHAM controls, J20SHAM mice showed markedly impaired
learning in the hidden platform (spatial) component, and this
deficit was reduced by MGENav1.1 cell transplants (Figures 2D
and 2E). In the water maze probe trial, only J20SHAM mice failed
to show a significant preference for the original platform location
(Figure 2F). J20MGE-Nav1.1 mice had better memory retention than
J20SHAM mice (Figure 2F). Thus, Nav1.1-enhanced interneuron
transplants reduce hAPP/Ab-induced behavioral and cognitive
deficits.
Next, we determined whether MGEWT and MGENav1.1 cell
transplants can reverse behavioral abnormalities in adult, symp-
tomatic J20 mice (Figures 2G–2I). To ensure that all J20 groups
had similar deficits at baseline, we tested untreated 2- to
3-month-old J20 and NTG mice in the open field (Figure 2G,
trial 1). We then bilaterally transplanted MGEWT or MGENav1.1
cells into equally impaired J20 groups and into NTG controls
and re-tested them at 4–7 months of age. Compared to NTG
controls, J20SHAM and J20MGE–WT mice had robust and compa-
rable hyperactivity and context-dependent habituation deficits in
the open field (Figures 2G and 2H), indicating that MGEWT cells
did not reduce these deficits in J20mice. However, these deficits
were reduced in J20MGE-Nav1.1 mice as compared to J20SHAM
controls (Figures 2G and 2H). In the water maze probe trial,
J20MGE-WT, but not J20MGE-Nav1.1, mice failed to favor the original
platform location (Figure 2I). J20MGE-Nav1.1 mice had bettermem-
ory retention than J20SHAM mice (Figure 2I).
Comparison of J20MGE-WT and J20MGE-Nav1.1 mice by ANOVA
and Bonferroni tests (Nieuwenhuis et al., 2011) revealed that
Nav1.1 overexpression in MGE cell transplants was required
for therapeutic effects to be observed in J20 mice (Figure S4).
We confirmed that all adult transplanted groups had similar
numbers of MGEWT- and MGENav1.1-derived GFP-positive inter-
neurons (4,797–5,941 GFP-positive cells per brain) (Figure S4A).
Thus, transplantation ofMGENav1.1, but not MGEWT, cells into the
brains of neonatal or adult J20 mice reduced behavioral abnor-
malities in J20 mice, suggesting that molecular optimization of
MGE cells is required for therapeutic benefit in brains with path-
ologically elevated levels of hAPP/Ab.
Nav1.1-Deficient Interneuron Transplants Impair
Behavioral Functions
Since reduced levels of endogenous Nav1.1 contribute to inhib-
itory and cognitive dysfunction in J20 mice (Verret et al., 2012),
we tested whether reduced Nav1.1 levels in transplanted inter-
neurons alter the behavior of NTG mice. MGE cells with reducedNav1.1 expression were obtained from heterozygous Nav1.1
knockin mice in which one Scn1a allele carries a point mutation
(R1407X) that introduces a premature stop codon and causes
Nav1.1 haploinsufficiency (Ogiwara et al., 2007). MGE cells
were unilaterally transplanted into the cortex and hippocampus
at P3–P5, and mice were analyzed at 6–8 months of age.
MGENav1.1–KI cell transplants impaired learning in the Morris
water maze in NTG mice, as shown by longer escape distances
and latencies and a lower percentage of trials in which the plat-
form was found (Figure 3A–3C). Compared to NTGMGE–Nav1.1
mice, NTGMGE–Nav1.1–KI mice displayed excessive freezing in a
fear conditioning test (Figure 3E). Thus, transplantation of
Nav1.1-deficient interneurons into otherwise healthy brains
caused learning deficits and behavioral alterations, suggesting
that loss of Nav1.1 changes the functionality of these cells in
ways that actively disrupt normal brain function.
We next compared the behavioral effects of MGENav1.1 and
MGENav1.1–KI cell transplants in J20mice. J20MGE–Nav1.1 mice per-
formed better than J20MGE–Nav1.1–KI mice in the Morris water
maze, as shown by shorter escape distances and latencies and
a higher percentage of trials in which the platformwas found (Fig-
ures 3A–3C). In the probe trial, J20MGE–Nav1.1 mice, but not
J20MGE–Nav1.1–KI mice, favored the original platform location (Fig-
ure 3D). Finally, J20MGE–Nav1.1–KI mice displayed more excessive
freezing in a fear-conditioning test than J20MGE–Nav1.1 mice (Fig-
ure 3F). All together, our behavioral data (Figures 2 and 3) suggest
that increased Nav1.1 levels in transplanted MGE cells are
required for therapeutic efficacy in J20 mice, and that reduced
Nav1.1 levels in these cells cause behavioral deficits in NTGmice.
Nav1.1 Levels Modulate AP Kinetics and Firing Rates in
Transplanted Interneurons
Increasing (MGENav1.1) or reducing (MGENav1.1-KI) Nav1.1 levels in
MGE cells strongly modulated their effects upon transplantation
into NTG and J20 mice. To explore how Nav1.1 levels modulate
intrinsic electrophysiological properties of transplanted MGE
cells, we carried out whole-cell patch-clamp recordings of
MGEWT-, MGENav1.1-, and MGENav1.1–KI-derived interneurons in
acute coronal cortical slices from NTG or J20 mice 6–11 months
after transplantations. Consistent with our histological data, we
identified roughly similar proportions of transplant-derived
fast-spiking (FS, n = 62 cells from 23 mice) and non-fast-spiking
(N-FS, n = 65 cells from25mice) interneuronswhen combining all
recorded cells. The transplant-derived FS and N-FS interneuron
subtypes displayed expected differences in electrophysiological
properties, including in AP firing rate, AP half-width, AP rise and
fall times, resting membrane potential, input resistance, and
membrane time constant (Figures 4 and S5).
To determine whether Nav1.1 levels affect AP properties, we
compared transplanted MGENav1.1-, MGENav1.1-KI-, and
MGEWT-derived interneurons in NTG mice in regard to cell type
(FS and N-FS), MGE genotype (WT, Nav1.1, and Nav1.1-KI),
and the interaction among these variables by two-way ANOVA
analyses. Importantly, Nav1.1 expression levels strongly
modulated AP kinetics in transplant-derived FS and N-FS inter-
neurons (Figures 4C and 4D). Compared to MGEWT-derived in-
terneurons, MGENav1.1–KI-derived interneurons had a wider AP,
slower AP rise and fall times, and a larger AP area, whereasNeuron 98, 1–15, April 4, 2018 5
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B C Figure 3. Reduced Nav1.1 Levels in Inter-
neuron Transplants Impair Behavioral Func-
tions
NTG and J20 mice received MGENav1.1 or
MGENav1.1–KI cell transplants unilaterally into the
hippocampus and cortex at P3–5 and were tested
in the Morris water maze and in a fear-conditioning
test at 6–8 months of age.
(A–C) Escape distances (A) and latencies (B) and
percentage of trials in which the platformwas found
(C) in the hidden-platform component of the Morris
water maze (n = 5–8 mice per group).
(D) Quadrant location preference during the probe
trial. *p < 0.05, **p < 0.01 versus nontarget quad-
rants by paired two-tailed t test.
(E and F) Fear-conditioning freezing responses
during training and for the 24-h context-test
intervals (1–5 min; test) in NTG (E) and J20 (F) mice
transplanted with MGENav1.1 or MGENav1.1–KI cells
(n = 7–12 mice per group). PSI, post-shock interval.
*p < 0.05, **p < 0.01 by repeated-measures ANOVA
and Bonferroni post hoc test (A–C, days 1–5) and
(E and F, 1–5 min). Values are mean ± SEM.
Numbers in bars indicate numbers of mice.
Please cite this article in press as: Martinez-Losa et al., Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a
Mouse Model of Alzheimer’s Disease, Neuron (2018), https://doi.org/10.1016/j.neuron.2018.02.029MGENav1.1-derived interneurons had faster AP kinetics. Thus,
Nav1.1 levels potently modulated AP kinetics, and MGENav1.1-,
MGENav1.1-KI-, and MGEWT-derived interneurons are functionally
different, providing potential cellular mechanisms that could
explain the benefit of molecular optimization of the transplant-
derived interneurons. We confirmed that Nav1.1 levels regulate
action potential kinetics using individual cells (Figure 4C) or
mice (Figure S6D) as the biological unit to calculate averages.
Interestingly, N-FS MGENav1.1-derived cells displayed a distinct
input-output relationship consisting of reduced AP firing at lower
current injection intensities (0–100 pA; p = 0.020), higher propor-
tional increases of AP firing rates at intermediate current inten-
sities (100–400 pA), and similar AP firing rates at higher current
intensities (400–500 pA). Thus, MGENav1.1-derived cells seem
to be less responsive at low intensities and to have a better
dynamic range to discriminate intermediate current intensities.
In addition, FS MGENav1.1-KI-derived cells had slower AP firing
rates in response to increased current injections and more pro-
nounced AP amplitude decrement during sustained firing than
MGEWT- and MGENav1.1-derived cells (Figures 4E and 4F).
Consistent with these results, deletion of Nav1.1 impaired AP
kinetics and firing in endogenous PV and SOM cells (Rubinstein
et al., 2015; Tai et al., 2014; Yu et al., 2006).
To assess potential effects of the pathologically altered host
brain, we compared AP properties of transplanted FS and
N-FS MGE-derived interneurons in NTG and J20 mice in regard
to host brain genotype (NTG and J20), MGE genotype (WT and
Nav1.1), and the interaction between them by two-way ANOVA
(Figure 5A; and NTG data in Figure 4). Consistent with the above
results, the FS and N-FS interneurons in NTG and J20 mice
displayed robust Nav1.1-dependent differences in AP kinetics;
however, the genotype of the host brain did not affect the AP
kinetics of transplanted MGEWT- or MGENav1.1-derived FS and
N-FS interneurons (Figures 5B and 5C). We confirmed these6 Neuron 98, 1–15, April 4, 2018results using individual cells (Figure 5B) or mice (Figure S6E) as
the biological unit to calculate averages. Comparison of MGEWT
and MGENav1.1 cells in J20 mice by two-way ANOVA revealed
that Nav1.1 overexpression was required for accelerating AP
kinetics in FS and N-FS cells in these mice (Figure S6). In J20
mice, MGENav1.1-derived FS cells also had increased AP firing
rates at higher current intensities (200–500 pA) as compared to
MGEWT-derived FS cells (Figures 5D and S6). Our results indi-
cate that Nav1.1 overexpression accelerates AP kinetics and
increases AP firing rates of MGENav1.1-derived FS interneurons
in J20 mice.
Nav1.1-Overexpressing, but Not Wild-Type, Interneuron
Transplants Counteract Network Hypersynchrony in
J20 Mice
Humans with AD—particularly early-onset and familial AD—and
hAPP-transgenic mice are prone to network hypersynchrony
and altered gamma oscillatory activity (Noebels, 2011; Palop
and Mucke, 2016; Vossel et al., 2016; Lam et al., 2017). To
determinewhether interneuron transplants suppress hAPP/Ab-in-
duced network hypersynchrony, we transplanted MGEWT or
MGENav1.1 cells bilaterally into the hippocampus and cortex of
2- to 3-month-old mice and analyzed the mice at 7 to 8 months
of age. We monitored spontaneous epileptiform discharges
(spikes/min) by intracranial EEG recordings and locomotor activ-
ity (movements; beambreaks/min) for 50min while mice explored
a novel environment. MGENav1.1 cell transplants reduced hyper-
activity (Figure 6A) and spike frequency (Figure 6B) in J20 mice.
The firing rates of PV-positive interneurons and gamma oscilla-
tory power increase during exploratory activity (Kemere et al.,
2013; Lapray et al., 2012). Consistent with this behavior-depen-
dent modulation of network function, spike rates in J20 mice
increased as they habituated to the novel environment, and their
exploratory activity decreased, most markedly in J20SHAM mice
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Figure 4. Nav1.1 Levels Regulate AP Kinetics in Fast-Spiking (FS) and Non-Fast-Spiking (N-FS) MGE-Derived Interneurons Transplanted in
NTG Mice
NTG mice received MGEWT, MGENav1.1, or MGENav1.1–KI cell transplants into the hippocampus and cortex at P3–5. Whole-cell patch-clamp recordings from
interneurons in the cortex of acute coronal brain slices were done at 6–11 months of age. FS: n = 11, 11, and 11 cells from 5 NTGMGE-WT, 4 NTGMGE-Nav1.1, and
3 NTGMGE-Nav1.1-KI mice, respectively. N-FS: n = 11, 26, and 6 from 4 NTGMGE-WT, 8 NTGMGE-Nav1.1, and 3 NTGMGE-Nav1.1-KI mice, respectively.
(A and B) Representative traces of AP firing recorded from cortical GFP-positive MGEWT-, MGENav1.1- or MGENav1.1–KI-derived FS (A) and N-FS (B) interneurons in
NTG mice evoked by 1 s current injections of 200 and 400 pA.
(C) Quantification of AP waveform properties of MGEWT-, MGENav1.1-, and MGENav1.1–KI-derived FS and N-FS interneurons in NTG mice. P values by two-way
ANOVA assessing cell type (FS and N-FS), MGE genotype (WT, Nav1.1, and Nav1.1-KI), and interaction.
(D) Representative traces of AP waveforms recorded from MGEWT-, MGENav1.1-, and MGENav1.1–KI-derived FS and N-FS interneurons in NTG mice.
(E) Mean number of APs in MGEWT-, MGENav1.1-, and MGENav1.1–KI-derived FS (top) and N-FS (bottom) interneurons evoked by the indicated incremental current
pulse intensities. *p < 0.05 and **p < 0.01 by repeated-measures ANOVA and Bonferroni test for 200–500 pA.
(F) Number of APs elicited at the maximum current injection intensity (top) and the AP decrement in the 1 s current pulse (bottom) in MGEWT-, MGENav1.1-, and
MGENav1.1–KI-derived interneurons. P values by two-way ANOVA assessing cell type (FS and N-FS), MGE genotype (WT, Nav1.1, and Nav1.1-KI), and interaction.
Values are mean ± SEM. Significant P values are in red. See also Figures S5 and S6.
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related (Figure 6D). Spike rates were highest at rest (0–9 beam
breaks/min), intermediate during low exploratory activity (10–49
beam breaks/min), and lowest during high exploratory activity
(50–150 beam breaks/min) (Figure 6E). Spike rates were lower in
J20MGE–Nav1.1 mice than in J20SHAM mice (Figure 6E). To deter-
minewhether Nav1.1 expression inMGE cells is required for ther-
apeutic effects in J20 mice, we compared J20SHAM, J20MGE-WT,
and J20MGE-Nav1.1 mice. Consistent with our behavioral data
(Figures 2 and S4), MGENav1.1, but not MGEWT, cells reduced
epileptiform activity in J20 mice (Figures 6F and 6G). Thus,
Nav1.1 enhancement of MGE cells is required for these trans-
plants to suppress hAPP/Ab-induced hypersynchrony.Reduced Behavioral-Activity-Associated Increases in
Gamma Oscillations Predict Locomotor Hyperactivity in
J20 Mice
Gamma oscillatory power in cortical networks increases dur-
ing sensory or cognitive tasks in humans and mice; the in-
creases predict better memory formation (Matsumoto et al.,
2013; Sederberg et al., 2007; Yamamoto et al., 2014) and
are associated with reduced rates of epileptiform spikes in hu-
mans and mice with network hypersynchrony (Matsumoto
et al., 2013; Verret et al., 2012). To determine whether
behavior-dependent modulation of gamma oscillations and
epileptiform spikes in J20 mice relates to their hyperactivity
and habituation deficits, we studied the relationship betweenNeuron 98, 1–15, April 4, 2018 7
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Figure 5. Transplanted MGENav1.1-Derived Interneurons in NTG and J20 Mice Exhibit Faster AP Kinetics and Their Function is Not Altered by
the Host Genotype
NTG and J20 mice received MGEWT or MGENav1.1 cell transplants into the hippocampus and cortex at P3–5. Whole-cell patch-clamp recordings from
interneurons in the cortex of acute coronal brain slices were done at 6–11 months of age. FS: n = 11, 17, 11, and 12 cells from 5 NTGMGE-WT, 7 J20MGE-WT,
4 NTGMGE-Nav1.1, and 4 J20 MGE-Nav1.1 mice, respectively. N-FS: n = 11, 9, 26, and 13 cells from 4 NTGMGE-WT, 6 J20MGE-WT, 8 NTGMGE-Nav1.1, and 4 J20 MGE-Nav1.1
mice, respectively.
(A) Representative traces of APs recorded from cortical GFP-positive MGEWT- or MGENav1.1-derived FS and N-FS interneurons in NTG and J20 mice evoked by
1 s current injections of 500 pA. Detail of APs (gray area).
(B) Quantification of AP waveform properties of MGEWT- and MGENav1.1-derived FS and N-FS interneurons in NTG (data from Figure 4C) and J20 mice. P values
by two-way ANOVA assessing MGE genotype (WT and Nav1.1), host brain genotype (NTG and J20), and interaction.
(C) Representative traces of AP waveforms recorded from MGEWT- and MGENav1.1-derived FS and N-FS interneurons in NTG and J20 mice.
(D) Mean number of APs evoked by the indicated incremental current intensities in MGEWT- and MGENav1.1-derived FS (top) and N-FS (bottom) interneurons
transplanted into NTG mice (data from Figure 4E) and J20 mice. J20MGE-WT versus J20MGE–Nav1.1 comparison, *p < 0.05 by repeated-measures ANOVA and
Bonferroni test for 200–500 pA.
(E) Number of APs elicited at the maximum current injection intensity (top) and the AP decrement in the 1 s current pulse (bottom) in MGEWT- and MGENav1.1-
derived interneurons transplanted in NTGmice (data from Figure 4F) and J20mice. P values by two-way ANOVA assessing MGE genotype (WT and Nav1.1), host
brain genotype (NTG and J20), and interaction.
Values are mean ± SEM. Numbers in bars indicate numbers of cells. Significant P values are in red. See also Figures S5 and S6.
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locomotor activity at 1-min intervals in J20SHAM and
J20MGE–Nav1.1 mice. Consistent with previous findings (Rubio
et al., 2012; Verret et al., 2012), J20SHAM mice had reduced
gamma power (Figure S7). Gamma power, which is predomi-
nantly regulated by PV cells (Cardin et al., 2009; Sohal et al.,
2009), was closely related to exploratory activity (Figures
7A–7C) (Kemere et al., 2013; Lapray et al., 2012). Linear
regression analysis revealed strong positive correlations8 Neuron 98, 1–15, April 4, 2018between exploratory activity and gamma power (Figure 7C).
Obtaining data at 1-min intervals allowed us to accurately
calculate the slope of the linear regression between explor-
atory activity and gamma power (relative to resting) for each
mouse. Thus, the slope reflects the modulation of gamma
power during exploratory activity. J20SHAM and J20MGE–Nav1.1
mice with less behavior-dependent modulation of gamma
power (flatter slopes) had higher levels of exploratory activity
(Figure 7D, top) and took longer to habituate (Figure 7D,
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Figure 6. MGENav1.1, but Not MGEWT, Cell Transplants Reduce Network Hypersynchrony in J20 Mice
Mice were sham-treated or transplanted bilaterally with MGEWT or MGENav1.1 cells at 2–3 months of age. EEGs were recorded at 7–8 months during a 50-min
exploration of a novel environment.
(A) Movements (beam breaks/min) during EEG recordings in the open field (n = 9–11 mice per J20 group).
(B) Spike rate averaged over the entire exploration period.
(C) Minute-by-minute spike rate. MGENav1.1 cells reduced spike rates in J20 mice.
(D) EEG recordings (top) and minute-by-minute spike rate and movements (bottom) for representative J20SHAM and J20MGE–Nav1.1 mice. Detail of epileptiform
spike (gray area).
(E) Spike rates in J20SHAM and J20MGE–Nav1.1 mice (n = 431–493 min of EEG recordings, 9–11 mice per group) by exploratory activity level (left) or movement
frequency (right). Treatment (p < 0.0001, F(2, 918) = 22.44), activity level (p < 0.0001, F(2, 918) = 53.67), and interaction (p = 0.572, F(2, 918) = 0.558) effects by
two-way ANOVA.
(F) Minute-by-minute spike rate of J20 mice transplanted with MGEWT cells and controls over 50 min. MGEWT cells did not change spike rates.
(G) Average spike frequencies of J20 mice transplanted with MGESHAM, MGEWT and MGENav1.1 cells.
*p < 0.05, ***p < 0.001 by repeated-measures ANOVA and Bonferroni test (A, C, and F) or by one-way ANOVA and Bonferroni test (B, E, G). Values are
mean ± SEM. Numbers in or above bars indicate number of mice.
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behavioral alterations in J20 mice (data not shown;
p = 0.668, J20SHAM; p = 0.5569, J20MGE-Nav1.1). These results
suggest that the extent of behavior-dependent modulation of
gamma oscillatory activity predicts behavioral performance
and that reduced modulation is closely related to hyperactivity
and habituation deficits in hAPP mice.Nav1.1-Overexpressing Interneuron Transplants
Enhance Behavior-Dependent Modulation of Gamma
Oscillations
Gamma oscillations aberrantly increase during seizures or
hypersynchronized network activity in epilepsy models (Howard
et al., 2014). MGE cell transplants reduce both these gamma
oscillation increases (Howard et al., 2014) and networkNeuron 98, 1–15, April 4, 2018 9
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A Figure 7. Reduced Behavior-Dependent
Modulation of Gamma Oscillations Predicts
Behavioral Deficits in J20 Mice
Mice were sham-treated or transplanted bilaterally
with MGENav1.1 cells at P3–5 or at 2–3 months of
age andwere tested at 7–8months (n = 16–18mice
per group).
(A) Minute-by-minute quantifications of gamma
power (30–80 Hz; top) and corresponding
30–80 Hz spectrograms (bottom) for representa-
tive J20SHAM and J20MGE–Nav1.1 mice.
(B) Exploratory activity and gamma power in
representative J20SHAM and J20MGE–Nav1.1 mice.
(C) Linear regression analyses showed strong
relationships between gamma power and explor-
atory activity (mice from A). Data points represent
minutes.
(D) Linear regression analyses showed strong
relationships between behavior-dependent in-
creases in gamma power (slopes) and total
movements in the open field (top) or time to
habituate to NTG control level (bottom) for
J20SHAM mice (left) and J20MGE–Nav1 mice (right).
Data points represent mice. Hyperactivity and
habituation deficits were strongly associated with
lower behavior-dependent modulation of gamma
power. Slopes (m) for J20SHAM and J20MGE–Nav1.1
mice were not significantly different (p = 0.169 and
0.853, respectively) by linear regression slope test.
See also Figure S7.
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et al., 2017; Hammad et al., 2015; Henderson et al., 2014; Hunt
et al., 2013). However, it is unknown whether MGE cell trans-
plants can enhance normal fluctuations of gamma oscillatory
activity during memory encoding (Matsumoto et al., 2013; Se-
derberg et al., 2007; Yamamoto et al., 2014). To determine
whether MGE cell transplants increase behavior-dependent
modulation of gamma oscillations, J20 mice were sham-treated
or transplanted with MGENav1.1 or MGEWT cells at 2 to 3 months
of age and tested at 4–7 months. Compared to MGESHAM,
MGENav1.1 but not MGEWT cell transplants enhanced the
increases of gamma power during exploratory activity (Fig-
ure 8A), which predict better behavioral performance in J20
mice (Figure 7). J20MGE-Nav1.1 mice had higher increases in
gamma power than J20SHAM mice (Figure 8A). Despite the elec-10 Neuron 98, 1–15, April 4, 2018trophysiological deficits in MGENav1.1–KI-
derived FS and N-FS interneurons
(Figure 4) and the behavioral abnormal-
ities these cells caused in NTG mice
(Figure 3), we were unable to detect
epileptiform discharges or altered
gamma oscillations in NTGMGE–Nav1.1–KI
mice (data not shown).
Periods of reduced gamma power
tend to be associated with increased
rates of epileptiform discharges in hu-
mans and mice with network hypersyn-
chrony (Matsumoto et al., 2013; Verret
et al., 2012). However, it is unclearwhether these phenomena are causally related and, if so,
whether epileptiform discharges cause (and therefore precede)
reductions in gamma power or vice versa. To address this
issue, we calculated the gamma power before and after each
epileptiform discharge in J20 mice. Gamma power decreased
abruptly before the discharges, reached the lowest level during
the discharges, and rapidly recovered after the discharges (Fig-
ure 8B). Thus, decreased gamma power precedes epileptiform
discharges, suggesting that the drop in gamma power is caus-
ally linked to the emergence of these events. Interestingly, only
MGENav1.1 cells prevented the drop in gamma power before
epileptiform discharges in J20 mice (Figure 8C), suggesting
that the drop is caused by interneuron impairment and
can be prevented by Nav1.1-overexpressing interneuron
transplants.
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Figure 8. MGENav1.1, but Not MGEWT, Cell Transplants Increase
Behavior-Dependent Modulation of Gamma Oscillations in J20 Mice
Mice were sham-treated or transplanted bilaterally with MGEWT or MGENav1.1
cells at 2–3 months of age and were tested at 7–8 months (n = 20 J20SHAM,
7 J20MGE-WT, and 9 J20MGE-Nav1.1 mice).
(A) Linear regression analyses showed strong relationships between gamma
power and exploratory activity for J20 mice transplanted with MGESHAM,
MGEWT, or MGENav1.1 cells. Compared to MGESHAM cells, MGENav1.1, but not
MGEWT, cells increased behavior-dependent modulation of gamma power
(top two panels). J20MGE-Nav1.1 mice had higher increases of gamma power
than J20MGE-WT mice (bottom). n = 7–11 mice per group, 431–492 min of EEG
recordings per group. ***p < 0.001 by linear regression slope test.
(B) Gamma power as a function of time before and after epileptiform spikes
(n = 493 spikes, 11 J20SHAM mice). Gamma oscillatory power decreased
steadily 40–50 s before epileptiform discharges and gradually recovered over
50–60 s. Values are mean ± SEM.
(C) MGENav1.1, but not MGEWT, cells reduced the drop in gamma power before
the spikes (n = 390–915 spikes per group from 15 J20SHAM, 5 J20MGE–WT, and
8 J20 MGE–Nav1.1 mice). ***p < 0.001 by linear regression slope test.
Values are mean ± SEM.
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This study shows that transplantation of Nav1.1-overexpressing
MGE-derived interneurons into brains of a mouse model
simulating key aspects of AD enhances behavior-dependent
modulation of gamma oscillatory activity, reduces network
hypersynchrony, and improves cognitive functions. Wild-type
interneuron transplants failed to restore brain functions, indi-cating that the therapeutic effects of the transplanted cells
depend on Nav1.1 levels. Moreover, transplantation of Nav1.1-
deficient interneurons in NTG mice induced learning deficits
and behavioral abnormalities, indicating that Nav1.1 levels in
interneurons critically impact cognitive functions. Thus, Nav1.1
deficiency confers an adverse gain of function on interneurons,
whereas Nav1.1 overexpression either enhances their normal
activities beyond a critical threshold or confers a beneficial
gain of function. At the cellular level, increased Nav1.1 levels
accelerated AP kinetics, whereas decreased Nav1.1 levels
slowed AP kinetics in transplant-derived FS and N-FS interneu-
rons in NTG mice. In J20 mice, enhanced Nav1.1 levels in
MGENav1.1-derived FS interneurons accelerated AP kinetics
and increased AP firing rates. Our findings highlight key differ-
ences among MGEWT, MGENav1.1-, and MGENav1.1–KI-derived
interneurons; the functional relevance of Nav1.1 levels in trans-
plant-derived interneurons; the potential of Nav1.1 and interneu-
rons as a therapeutic target in AD; and the value of molecularly
modifying brain cell transplants to enhance their functions.
We identified three main cellular and network mechanisms
that may underlie the beneficial effects of interneuron trans-
plants, all of which depended on Nav1.1 levels. MGENav1.1 but
not MGEWT cell transplants accelerated AP kinetics, enhanced
behavior-dependent increases in gamma oscillatory activity,
and reduced network hypersynchrony in hAPP-J20 mice.
Increased Nav1.1 Levels Accelerate AP Kinetics in
Transplanted Interneurons
Nav1.1 deficiency in endogenous inhibitory interneurons slows
AP kinetics, including AP half-width, and reduces AP firing rates
in a gene-dose-dependent manner (Rubinstein et al., 2015; Tai
et al., 2014; Yu et al., 2006). We observed similar AP deficits in
transplanted MGENav1.1-KI-derived interneurons, confirming the
functional relevance of Nav1.1 levels in inhibitory cells. Nav1.1
overexpression accelerated AP kinetics (spike waveforms) in
transplant-derived FS and N-FS interneurons in NTG and
hAPP-J20 mice and increased AP firing rates in MGENav1.1-
derived FS interneurons in hAPP-J20 mice. Faster AP kinetics
and higher firing rates in MGENav1.1-derived FS interneurons of
J20 mice may have several functional benefits, including incom-
plete sodium channel inactivation during repetitive firing, which
enables high-frequency firing in fast-spiking interneurons; resis-
tance to frequency-dependent AP broadening during repetitive
firing; and enhanced gamma oscillations (Bean, 2007; Carter
and Bean, 2009). Our data suggest that faster AP kinetics and
higher AP firing rates are the key cellular mechanisms underlying
the therapeutic effects of MGENav1.1-derived interneurons in
J20 mice.
MGENav1.1 Cell Transplants Enhance Behavior-
Dependent Gamma Oscillations and Cognitive
Functions
Since increasing the AP firing rate of PV cells promotes gamma
oscillatory activity (Cardin et al., 2009; Sohal et al., 2009), the
improvement of gamma oscillations in MGENav1.1-transplanted
hAPP-J20 mice likely reflects increased activity or synchrony
of transplant-derived PV cells. Indeed, MGENav1.1-derived FS
interneurons had higher firing rates than MGEWT-derived FSNeuron 98, 1–15, April 4, 2018 11
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these increased firing rates contributed to the enhanced gamma
power in J20MGE-Nav1.1 mice. Importantly, increases in gamma
oscillatory activity during cognitive tasks predict effective mem-
ory formation in humans and mice (Matsumoto et al., 2013;
Sederberg et al., 2007; Yamamoto et al., 2014). Consistent
with these findings, reduced behavior-dependent modulation
of gamma oscillations predicted habituation deficits and hyper-
activity in hAPP-J20 mice. The inability of these mice to enhance
gamma oscillatory activity during exploration of a novel environ-
ment may contribute to their learning and memory deficits.
Indeed, MGENav1.1-derived interneuron transplants increased
the behavior-dependent modulation of gamma oscillation and
improved cognitive functions.
MGENav1.1 cell transplants also reduced excessive freezing
in hAPP-J20 mice during the learning and recall phases of a
fear-conditioning test. Excessive freezing was also seen in
NTGMGE-Nav1.1-KI mice without detectable epileptic activity, indi-
cating that dysfunction of a small proportion of interneurons is
sufficient to cause this behavioral abnormality. Consistent with
our results, optogenetic inhibition of PV cells causes excessive
fear-like responses inmicewithout seizures (Courtin et al., 2014).
Interestingly, MGENav1.1 cells transplanted into J20 mice had
beneficial effects on behavioral and network functions despite
the Nav1.1 hypofunction of endogenous interneurons in these
mice. Yet, MGENav1.1-KI cells transplanted into NTG mice had
detrimental effects on behavioral functions. These results indi-
cate that relatively small numbers of transplanted MGE cells
with modified Nav1.1 function can exert dominant positive or
dominant negative effects depending on the direction of change
in Nav1.1 level. In principle, these opposing effects could be
caused by modulation of the same or distinct cellular and
network mechanisms, including complex interactions between
transplanted and endogenous neurons.
Network Hypersynchrony and Gamma Oscillations in
Mice and Humans
Reduced gamma oscillatory activity seems to be mechanistically
linked to network hypersynchrony in hAPP-J20mice (Verret et al.,
2012) and in humans with epilepsy (Matsumoto et al., 2013).
Notably, gamma power dropped abruptly seconds before
epileptiform discharges, and reached the lowest level during
the discharges. Thus, reduced gamma power may be mechanis-
tically linked to the generation of epileptiform discharges, at
least in hAPP-J20 mice. In humans with epilepsy, memory
encoding is associated with increased gamma oscillations and
reduced epileptiform discharges (Matsumoto et al., 2013). Thus,
enhancing gamma oscillations by therapeutic interventions may
reduce network hypersynchrony. Indeed, MGENav1.1-trans-
planted hAPP-J20 mice had increased behavior-dependent
gamma oscillatory activity and reduced network hypersynchrony,
implicating Nav1.1-deficient inhibitory interneurons and impaired
gamma oscillations as potential pathogenic drivers.
Interneuron Transplant Efficacy and Disease-Specific
Molecular Optimization
MGEWT-derived interneurons did not reduce network and cogni-
tive dysfunctions in hAPP-J20 mice, whereas they did in human12 Neuron 98, 1–15, April 4, 2018apoE4-KI/hAPP-J20 mice (Tong et al., 2014) and pilocarpine-
treated nontransgenic mice (Casalia et al., 2017; Hunt et al.,
2013). Several mechanisms may account for the greater efficacy
ofMGEWT cells in these diseasemodels. First, behavioral pheno-
types in apoE4-KI/hAPP-J20 mice largely depend on APOE4,
as soluble Ab levels and amyloid deposition are reduced by
>75% in APP mice that lack mouse Apoe (Bales et al., 1999;
Bien-Ly et al., 2012; Kim et al., 2011). Second, pilocarpine-
treated (Casalia et al., 2017; Hunt et al., 2013) and apoE4-KI
mice with or without hAPP expression (Tong et al., 2014) have
severe loss of hippocampal interneurons, particularly of SOM
cells in the hilus of the dentate gyrus. Thus, hippocampal MGE
transplants may primarily serve to replace the lost interneurons.
In hAPP-J20 mice, however, interneurons—particularly PV cells
in the parietal cortex—are not depleted but become dysfunc-
tional as a result of Nav1.1 depletion (Verret et al., 2012).
Thus, disease-specific molecular optimization of cell transplants
might be required to achieve therapeutic benefits in some cir-
cumstances, but not others.
Translational Opportunities for Brain Cell Transplants
Great caution needs to be applied when trying to extrapolate
from animal models to human diseases. Bearing this caveat
in mind, we find it promising that transplantation of MGENav1.1
cells into the brains of symptomatic adult J20 mice reduced
cognitive deficits and behavioral alterations, even though it did
not change the early amyloid pathology. Because the long-
term efficacy and safety of anti-Ab treatments remains uncertain
(Cummings et al., 2017), it is important to explore alternative and
complementary strategies to counteract effects that mediate
AD-related network dysfunction and cognitive decline. Based
on the data presented here and others reviewed elsewhere
(Palop and Mucke, 2016), we consider the dysfunction of inter-
neurons and the hypofunction of Nav1.1 worthy targets in this
regard.
Notably, interneuron dysfunction and abnormal oscillatory
network activities are associated not only with AD, but also
with autism, schizophrenia, and other cognitive disorders (Faz-
zari et al., 2010; Kepecs and Fishell, 2014; Sohal et al., 2009;
Verret et al., 2012). Interneuron transplantation strategies might
be beneficial in several of these disorders (Southwell et al.,
2014). Rapid advances in cell reprogramming approaches may
enable the generation of human cells that closely resemble
MGE-derived interneuron precursors before long (Cunningham
et al., 2014; Liu et al., 2013). Our findings suggest that, for these
cells to reach their maximal therapeutic potential, they may need
to be further engineered to adapt their biological activities to the
pathological environment into which they are transplanted.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
We studied heterozygous transgenic mice expressing human amyloid precursor protein (hAPP) with the Swedish and Indiana FAD
mutations (line J20) and nontransgenic (NTG) littermate controls(Mucke et al., 2000). F1 offspring from crosses between male J20
C57BL/6J mice and female NTG FVB/N mice were analyzed. To identify inhibitory interneurons derived from the medial ganglionic
eminence (MGE), we used BAC transgenic FVB/Nmice expressing enhanced green fluorescent protein (eGFP) directed by Lhx6 reg-
ulatory sequences (Lhx6GFP mice) (Cobos et al., 2006). To increase Nav1.1 expression levels by 25% (Verret et al., 2012), we used
Scn1a-BAC transgenic FVB/N mice from line 1 overexpressing wild-type murine Nav1.1 (Nav1.1-BAC mice) (Tang et al., 2009). To
reduce Nav1.1 expression levels, we used Nav1.1 knockin mice carrying a premature stop codon point mutation of the mouse Scn1a
gene (Nav1.1-R1407X mice) (Ogiwara et al., 2007). Unless indicated otherwise, measurements were done in sex-balanced groups
by investigators who were unaware of the genotype and treatment of the mice. Mice had free access to food (Picolab Rodente1 Neuron 98, 1–15.e1–e5, April 4, 2018
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Mouse Model of Alzheimer’s Disease, Neuron (2018), https://doi.org/10.1016/j.neuron.2018.02.029Diet 20; LabDiet, St Louis, MO) and water and weremaintained on a regular light/dark (12 hours on/12 hours off) cycle. For harvesting
of brain tissue, mice were deeply anesthetized and flush-perfused transcardially with saline. Brains were drop-fixed in 4% phos-
phate-buffered paraformaldehyde for 24–48 h. All experiments were approved by the Institutional Animal Care and Use Committee
of the University of California, San Francisco.
METHOD DETAILS
MGE Transplants
At embryonic (E) day 13.5, brains from Lhx6GFP, Lhx6GFP/Nav1.1-BAC, or Lhx6GFP/Nav1.1-R1407X FVB/N mice were placed in
ice-cold L-15 medium, and the ventricular and subventricular zones of the anterior part of the MGE were dissected as described
(Alvarez-Dolado et al., 2006; Zipancic et al., 2010) to isolate MGEWT, MGENav1.1, or MGENav1.1–KI, respectively. To generate MGEWT
cells, we crossed homozygous Lhx6GFP+/+ males with wild-type females to produce Lhx6GFP+/– embryos. To generate MGENav1.1
cells, we crossed Lhx6GFP+/+Nav1.1-BAC+/– males with Lhx6GFP+/+Nav1.1-BAC+/– females to produce Lhx6GFP+/+, Lhx6GFP+/+/
Nav1.1-BAC+/– and Lhx6GFP+/+/Nav1.1-BAC+/+ embryos. Among 189 offspring from independent breedings between Nav1.1-
BAC+/– males and Nav1.1-BAC+/– females 70.4% were Nav1.1-BAC positive, suggesting that such crosses yield both heterozygous
and homozygous Nav1.1-BAC transgenic mice. To generate MGENav1.1-KI cells, we crossed Nav1.1-R1407X+/– males with
Lhx6GFP+/+ females to produce Lhx6GFP+/–Nav1.1-R1407X+/+ and Lhx6GFP+/–Nav1.1-R1407X+/– embryos. Embryonic MGEs from
2–3 litters (10–20 embryos) were dissected, pooled, and transplanted into 10–20 mice. Thus, MGENav1.1 and MGENav1.1–KI precur-
sors likely contained 70% and 50% cells with increased (Nav1.1-BAC+/– or Nav1.1-BAC+/+) or decreased (Nav1.1-R1407X+/–)
Nav1.1 expression, respectively. For the electrophysiological experiments, embryonic MGEs from individual embryos were
dissected and transplanted into 1–2mice. The rest of the brain post MGE dissection was collected from each embryo and genotyped
for flag-Nav1.1 or Nav1.1-KI to identify MGE cell genotypes.
At E13.5, the density of MGE embryonic interneuron progenitors is at its peak, and the MGE is clearly delineated by a sulcus from
the lateral ganglionic eminence (LGE). Tissue explants were collected in 1 mL of L-15medium containing DNase I (10–100 mg/ml) and
mechanically dissociated by repeated pipetting through a 200 mL plastic tip. MGE cell number and viability (80%) were determined
by trypan blue exclusion. The cells were pelleted by centrifugation (2 min, 800 x g) and resuspended in L-15 medium at
0.1–0.5x106 cells/ml. MGE cell suspensions were front-loaded into beveled glass micropipettes (60–150-mm tip diameter) prefilled
with pure mineral oil and then with L-15 medium. A microinjector and stereotaxic frame were used to deliver a total of
0.5–1.0x106 MGE cells per mouse distributed bilaterally across 14 (adults) or 8 (neonatal) cortical and hippocampal sites
(50–100 nL per site) through four injection sites. Stereotaxic coordinates for adults were: anterior injection sites A –0.7 from the
bregma, L ± 2.4, D 1.8, 1.4, and 1.0 (from the skull surface); posterior injection sites A –1.7 from the bregma, L ± 1.4, D 2.0, 1.4,
0.8, and 0.5 (from the skull surface). For neonates, anterior injection sites A –3.0 from the naison at a 30 angle, L ± 2.8, D 2.0 and
1.5 (from the skull surface); posterior injection sites A –4.5 from the naison at a 30 angle, L ± 3.0, D 3.0 and 1.5 (from the skull surface).
For Figure 3, neonatal NTG and J20 mice received unilateral transplants of MGENav1.1 and MGENav1.1–KI cells into the cortex and
hippocampus.
For stereotaxic injections, adult mice were anesthetized with avertin (tribromoethanol, 250 mg/kg) and neonates by hypothermia
induced by placement on ice until the pedal reflex was abolished. MGEWT orMGENav1.1 cells were transplanted into the hippocampus
and cortex of neonatal (P3–5) or 2–3-month-old NTG or J20 mice to generate NTGMGE-WT, J20MGE-WT, NTGMGE-Nav1.1 and
J20MGE-Nav1 mice. Sham-transplanted groups (NTGSHAM and J20SHAM) received the same treatment, but the L-15medium contained
no MGE cells.
Immunohistochemistry
Tissue preparation and immunohistochemistry were done as described (Palop et al., 2011). After fixation, brains were cryoprotected
in 30% sucrose in phosphate-buffered saline (PBS) for 2 days and sectioned with a sliding microtome (Leica Microsystems) into
30-mm sections. Ten stereological subseries sections from each hemibrain were stored in a solution containing 30% glycerol,
30% ethylene glycol, and 40% PBS at –20C until staining. Primary antibodies used included rabbit anti-GFP (1:3,000; Life Technol-
ogies), chicken anti-GFP (1:500; Aves Labs), rabbit anti-Nav1.1 (1:500; Alomone), mouse anti-parvalbumin (1:3,000; Swant), rabbit
anti-parvalbumin (1:3,000; Swant), rat anti-somatostatin (1:50; Novus), rabbit anti-neuropeptide Y (1:2000; Immunostar), rabbit anti-
Iba-1 (1:1000; Wako), rabbit anti-GFAP (1:3000; Sigma), and biotinylated 82E1 (1:1000; Immuno-Biological Laboratories). Primary
antibodies were detected with biotinylated donkey anti-rabbit (1:500; Jackson ImmunoResearch), Alexa Fluor 488 donkey anti-rabbit
(1:300; Life Technologies), Alexa Fluor 488 donkey anti-chicken (1:300; Life Technologies), Alexa Fluor 594 donkey anti-rat (1:300;
Life Technologies), Alexa Fluor 594 donkey anti-mouse (1:300; Life Technologies), or Alexa Fluor 594 donkey anti-rabbit (1:300;
Life Technologies).
Histological Quantifications
In Lhx6GFP BAC transgenicmice, GFP expression is directed by the interneuron-specific Lhx6 regulatory sequences, andGFP is spe-
cifically expressed in embryonic MGE progenitors and in mature inhibitory interneurons derived from them (Cobos et al., 2006). All
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GFP-positive cells were counted in 6–15 mice per group; from these counts, we estimated the total number of GFP-positive cells per
brain. To identify MGE-derived interneuron subtypes, sections were double-labeled by fluorescence immunohistochemistry for GFP
(green) and for PV, SOM, or NPY (red). Images were captured with an Axiocam HRc camera and Zen Lite 2012 software (Carl Zeiss)
mounted on a fluorescence microscope (Olympus Bx41) at 40x magnification. A total of 1,449 GFP-positive cells (n = 4 mice per
group) were analyzed, including PV cells (n = 186/568 GFP-positive cells), SOM (n = 186/487 GFP-positive cells), and NPY
(n = 26/394 GFP-positive cells). For quantification of glia activation, brain sections were double-labeled by fluorescence immunohis-
tochemistry for transplanted GFP-positive MGE-derived interneurons (green) and for Iba-1-positive microglia or GFAP-positive
astrocytes (red). All images were captured at 20x magnification using the same image acquisition settings with the Keyence BioRevo
BZ-9000 microscope and BZ-II Viewer and Analyzer software. To determine glia activation, transplanted GFP-positive MGE-derived
interneurons were identified and the fluorescence intensity of Iba-1 or GFAP staining surrounding the transplanted cells or baseline
intensity away from the cells were quantified using ImageJ. A total of 80 square blocks of area surrounding transplanted cells and
80 blocks of baseline fluorescence were quantified for microglia and astrocytes respectively (n = 3-4 mice per group).
Whole-Cell Recordings
Mice (aged 8–9 months) were anesthetized with avertin (tribromoethanol, 250 mg/kg) and perfused with ice-cold dissection solution
containing (in mM): 93 NMDG, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 ascorbic acid, 2 thiourea, 3 sodium
pyruvate, 12 N-acetyl-L-cysteine, 10 MgSO4, and 0.5 CaCl2, pH 7.3. Brains were removed and maintained in ice-cold dissection
solution for acute slice preparation. Coronal 300-mm-thick slices were prepared using a vibratome and transferred to a recovery
chamber for 10 min containing dissection solution warmed to 35C. Slices were then incubated for 1 h at room temperature in a
modified artificial cerebral spinal fluid (ACSF) containing (in mM): 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose,
5 ascorbic acid, 2 thiourea, 3 sodium pyruvate, 12 N-acetyl-L-cysteine, 2 MgSO4, and 2 CaCl2, pH 7.3. Until recordings were
performed, the slices were maintained in oxygenated standard ACSF containing (in mM): 119 NaCl, 2.5 KCl, 1 NaH2PO4,
26.2 NaHCO3, 11 glucose, 1.3 MgSO4, and 2.5 CaCl2.
Slices were transferred to a recording chamber and continuously perfused with standard ACSF at 32C. Transplanted GFP-ex-
pressing interneurons were identified by epifluorescence and infrared differential interference contrast on an upright microscope
(BX51WIF, Olympus). Whole-cell patch-clamp recordings were done with internal solution containing (in mM): 135 K-gluconate,
10 HEPES, 0.1 EGTA, 5 KCl, 2 MgCl2, 4 Mg-ATP, 0.3 Na-GTP, pH 7.3. Patch pipette resistance was 3–5 MU. Picrotoxin
(100 mM), CNQX (10 mM), and D-AP5 (100 mM) were added to the ACSF to block synaptic inputs. Recordings were obtained with
a Multiclamp 700B amplifier (Molecular Devices), digitized at 10 kHz, and acquired with WinLTP software (version 1.11b, University
of Bristol). Access resistance was continuously monitored throughout the recordings and any neuron with > 20MU or > 20% change
in access resistance was excluded from the analysis. The liquid junction potential was not corrected. Resting membrane potential
was determined upon initiating whole-cell configuration. In current clamp mode, neurons were held at 60 mV, and current was in-
jected in incremental steps of 1 s duration. Current steps ranged from 60 to 500 pA (60, 40, 20, 20, 40, 60, 80, 100, 200, 300,
400 and 500 pA). The AP waveform kinetics were analyzed by the AP width at half maximum height, the 10%–90% rise time, and the
90%–10% fall time from the first AP in response to a 1 s current injection at 500 pA. The AP area (ms*mV) was the integral of the first
AP waveform in response to a 1 s current injection at 500 pA. Maximum AP # / 1 s at 20–500 pA was the maximum number of APs
in response to a 1 s current injection at any current intensity (20–500 pA). AP threshold was defined as the voltage of the action
potential where dV/dt first exceeded 15 mV/ms. The initial AP rate at 500 pA was calculated from the intervals between the initial
10 APs in response to a 1 s current injection at 500 pA. Membrane time constant was estimated from the best fit of a single
exponential to the initial hyperpolarization during a 60 pA current step. Spike amplitude was calculated as the voltage difference
between the resting membrane potential and the peak of the first evoked AP. Recordings were analyzed with pClamp 10.4 (Axon
Instruments). Experiments and analysis were done blind to mouse and MGE cell genotype. FS and N-FS cells were defined by their
intrinsic properties, mainly the maximum number of APs in response to a 1 s current injection, the AP half-width and the resting
membrane potential (Figures S5A–S5C). From the 130 cells recorded, we excluded 3 cells that we could not properly classify since
they had mixed N-FS and FS properties.
Behavioral Tests
Morris water maze
The water maze pool (122-cm diameter) contained opaque white water with a 12x12-cm platform submerged 1.5 cm below the sur-
face. For spatial training sessions, mice were trained to locate the hidden platform during 5 or 6 consecutive days. Each day, mice
received two training sessions 4 h apart consisting of two 60 s trials 10min apart. The hidden platform location remained constant and
the entry points were changed semirandomly between trials. Four hours after the last training session, the platform was removed and
a 60 s probe trial was done(Verret et al., 2012). Performance was monitored with an EthoVision video tracking system (Noldus Infor-
mation Technology). Distance swumor time to reach the hidden platformwas used tomeasure performance in the training phase. For
the probe trial, we measured the number of times mice crossed the original platform location plus 6 cm around it (target location) or
the equivalent positions in the other three quadrants (other locations).e3 Neuron 98, 1–15.e1–e5, April 4, 2018
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Exploratory locomotor activity was measured in four identical clear plastic open-field chambers (40 3 40 3 30 cm) with two
16 3 16-photobeam arrays to detect horizontal and vertical movements (automated Flex-Field/Open Field Photobeam Activity
System). Mice were placed in one of the chambers for 5 min per session. Total horizontal movements (beam breaks), both fine
and ambulatory, were recorded. For the habituation studies, each mouse was always retested in the same chamber. The apparatus
was cleaned with 70% ethanol between trials.
Y-maze
The Y-maze consisted of three 70-cm arms. The mouse was placed in one of the arms and was allowed to move freely for 6 min. The
total distance traveled was measured. Performance was monitored with the EthoVision video-tracking system.
Contextual fear conditioning test
Fear conditioning was performed in four identical computer-controlled chambers (28 3 21 3 22 cm) (Med Associates). The floor of
each chamber had 18 stainless steel rods (4-mm diameter, 1.5 cm apart) connected to a shock scrambler and generator, which,
together with internal ventilation fans, supplied background noise of 70 dB. For the training session (day 1), after 5-min exposure
to the chamber (to record baseline freezing), mice were given four 2 s shocks (0.45 mA) 2 min apart. For the 24-h context testing,
mice were placed in the same chamber for 5 min. Freezing behavior, defined as the absence of any visible movement except that
required for respiration, was automatically recorded by a video-tracking system (motion threshold = 18, detection method = linear;
Med Associates). The chambers were cleaned with 70% ethanol after each mouse. Mice were singly housed three days before and
during the water maze testing but not for the other tests.
Recordings of EEG and Locomotor Activity Levels
Mice were implanted for video EEG monitoring after anesthesia with intraperitoneal avertin (tribromoethanol, 250 mg/kg) as descri-
bed(Verret et al., 2012). Teflon-coated silver wire electrodes (0.125-mm diameter) soldered to a multichannel electrical connector
were implanted into the subdural space over the left frontal cortex (1 mm lateral and anterior to the bregma) and the left and right
parietal cortex (2 mm lateral and posterior to the bregma). The left frontal cortex electrode was used as a reference. All EEG record-
ings were done out at least 10 days after surgery on freely movingmice in an open-field chamber (403 403 30 cm) during themiddle
part of the daylight cycle. Exploratory locomotor activity (beam breaks/min) was measured with an automated Flex-Field/Open Field
Photobeam Activity System (San Diego Instruments). Total movements included fine and ambulatory horizontal movements and
vertical movements. Movement frequencies were defined as follow: resting (0–9 beam breaks/min or 0–5 cm/min), low (10–49
beam breaks/min or 5–35 cm/min), and high (50–150 beam breaks/min or 35–110 cm/min). EEG activity was recorded with
Harmonie software at 200 Hz sampling rate (version 5.0b, Stellate) for 50 min.
To determine the time to habituate to NTG control level in the open field (Figure 7C), we calculated the y-intercept at 40 beam
breaks/min (habituated basal activity) for each mouse by linear regression analyses, using the 50-min data points of movement
frequency (x; beam breaks/min) and time (y; min). The number of sharp-wave discharges (spikes) was automatically detected
with a Gotman spike detector (threshold 6; Harmonie, Stellate) or with a custom-made algorithm and LabChart 7 Pro software
(AD Instruments). Spikes recorded from left and right hemibrains were added and shown as epileptiform spikes/min.
For spectral analyses, 50-min segments of unfiltered EEG recordings (sampling rate 200 s-1) from freely moving mice were
imported and analyzed using LabChart 7 Pro software (AD Instruments). The 30–90-Hz band was used to calculate gamma power,
and a 58–62-Hz notch filter was applied to remove potential electrical noise. To obtain spectral power, we subjected the recordings to
a fast Fourier transform (FFT) with a Hann cosine-bell window with 50% overlap between windows of 500-ms epochs. FFT was done
with a 512 point FFT size to obtain a resolution of 0.39 Hz. The total signal amplitude or power in V2 in each 500-ms epoch was taken
to represent the magnitude of gamma oscillatory power. The gamma power values for each 500-ms epoch were further averaged
over 60 s of EEG recording, using the median values, to remove potential noise. Finally, signals from both hemibrains were averaged
to obtain the gamma power values for each mouse.
To calculate relative gamma power, the y-intercept at 0 movements/min was calculated for each mouse by linear regression an-
alyses using the 50-min data points of movement frequency (x; beam breaks/min) and the absolute gamma power (y; V2) (Figures 7
and 8). The y-intercept of the absolute gamma power value was used to normalize the 50 min of EEG data points of gamma power
within eachmouse, therefore, it was defined as 1.0 (gamma power relative to resting). For calculation of gamma power before spikes
(Figure 8), the gamma power for each 100-ms epoch was calculated for the 50 min of EEG recordings for each mouse as described
above. Spikes for each 100-ms epoch and epochs to the next spike were calculated. Power spectrum data (Figure 6) was extracted
using Spike2 software version 8 with FFT size 1024 (resolution 0.1953) and Hanning window function. NTG and J20 mice were
matched based on locomotor activity to avoid locomotor activity-dependent effects on power.
QUANTIFICATION AND STATISTICAL ANALYSIS
Blindcoding and Randomization
Investigators who carried outmeasurements were blinded with respect to the genotype of mice and the nature of the transplants they
had received. Mice of the same genotype were randomly assigned to receive different types of transplants.Neuron 98, 1–15.e1–e5, April 4, 2018 e4
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Statistical analyses were done with STATA 11.2 or Prism 6.0. Graphs were generated with Prism 6.0. As indicated in the figure
legends, differences among multiple means were assessed by one-way or two-way ANOVA and Bonferroni post hoc tests. The
P values of the Bonferroni tests are indicated in the figure panels with the following significance levels, *p < 0.05, **p < 0.01, and
***p < 0.001. Two-way ANOVA P values for the factors and interactions are indicated in the figure legends. Number (n) of mice or cells
for all statistical analyses is indicated in each graph or in the legend. Learning curves in the Morris water maze, fear-conditioning, and
novel-environment, open-field tests were analyzed by repeated-measures ANOVA and Bonferroni post hoc tests. Linear regression
analyses were used to calculate slopes or y-intercept and to determine significant differences among groups. Null hypotheses were
rejected at the 0.05 level.e5 Neuron 98, 1–15.e1–e5, April 4, 2018
